Syntax Advisors »

Regeneron Pharmaceuticals shares owned by Syntax Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Syntax Advisors from 13F filings

Historical chart of Syntax Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Syntax Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Syntax Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $232k 282 822.96
2023-06-30 $221k 307 718.54
2023-03-31 $263k 320 821.67
2022-12-31 $231k 320 721.49
2022-09-30 $247k 359 688.02
2022-06-30 $251k 425 590.59
2022-03-31 $251k 359 699.16
2021-12-31 $246k 390 630.77